PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 137 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $134,000 | +15.5% | 8,059 | +91.1% | 0.00% | – |
| Q2 2023 | $116,000 | +90.2% | 4,217 | +60.1% | 0.00% | – |
| Q1 2023 | $61,000 | +1.7% | 2,634 | -52.5% | 0.00% | – |
| Q4 2022 | $60,000 | +757.1% | 5,543 | +583.5% | 0.00% | – |
| Q3 2022 | $7,000 | +75.0% | 811 | +59.0% | 0.00% | – |
| Q2 2022 | $4,000 | -94.4% | 510 | -83.0% | 0.00% | – |
| Q1 2022 | $71,000 | -79.4% | 3,000 | -70.2% | 0.00% | – |
| Q4 2021 | $345,000 | +305.9% | 10,067 | +110.4% | 0.00% | – |
| Q3 2021 | $85,000 | -43.0% | 4,785 | +43.7% | 0.00% | – |
| Q2 2021 | $149,000 | +73.3% | 3,330 | +0.2% | 0.00% | – |
| Q1 2021 | $86,000 | +258.3% | 3,324 | +179.3% | 0.00% | – |
| Q4 2020 | $24,000 | +140.0% | 1,190 | +138.0% | 0.00% | – |
| Q3 2020 | $10,000 | +11.1% | 500 | 0.0% | 0.00% | – |
| Q2 2020 | $9,000 | – | 500 | +861.5% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 52 | -95.3% | 0.00% | – |
| Q4 2019 | $8,000 | +166.7% | 1,102 | +120.4% | 0.00% | – |
| Q4 2018 | $3,000 | -40.0% | 500 | -1.4% | 0.00% | – |
| Q3 2018 | $5,000 | +66.7% | 507 | +26.8% | 0.00% | – |
| Q2 2018 | $3,000 | +50.0% | 400 | +122.2% | 0.00% | – |
| Q1 2018 | $2,000 | +100.0% | 180 | +153.5% | 0.00% | – |
| Q4 2017 | $1,000 | -92.3% | 71 | -90.6% | 0.00% | – |
| Q3 2017 | $13,000 | +1200.0% | 758 | +1357.7% | 0.00% | – |
| Q2 2017 | $1,000 | -66.7% | 52 | -78.6% | 0.00% | – |
| Q1 2017 | $3,000 | -62.5% | 243 | -31.9% | 0.00% | – |
| Q4 2016 | $8,000 | +100.0% | 357 | +78.5% | 0.00% | – |
| Q3 2016 | $4,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |